Harrow, Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Harrow, Inc. and other ETFs, options, and stocks.

About HROW

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development.

CEO

Mark L. Baum

CEOMark L. Baum

Employees

382

Employees382

Headquarters

Nashville, Tennessee

HeadquartersNashville, Tennessee

Founded

2006

Founded2006

Employees

382

Employees382

HROW Key Statistics

Market cap

1.04B

Market cap1.04B

Price-Earnings ratio

-46.81

Price-Earnings ratio-46.81

Dividend yield

—

Dividend yield—

Average volume

614.22K

Average volume614.22K

High today

$28.48

High today$28.48

Low today

$25.57

Low today$25.57

Open price

$25.63

Open price$25.63

Volume

638.20K

Volume638.20K

52 Week high

$59.23

52 Week high$59.23

52 Week low

$15.97

52 Week low$15.97

HROW News

TipRanks 4d

Major Shareholder Cashes In on Harrow Health Stock!

New insider activity at Harrow Health ( (HROW) ) has taken place on May 15, 2025. Protect Your Portfolio Against Market Uncertainty Opaleye Management Inc., a...

People also own

Based on the portfolios of people who own HROW. This list is generated using Robinhood data, and it’s not a recommendation.